Inpatient Parkinson’s Care: Challenges and Special Considerations

Jeryl Ritzi T. Yu

Apr 2023 DOI 10.35460/2546-1621.2023-0032     Access   

Abstract

The hospital is often a haven for people in need of care. However, for people with Parkinson’s disease (PD), hospitalizations can turn into a nightmare. People with PD are admitted to the hospital more frequently than those without PD. Infections, metabolic changes, exposure to anesthesia, changes in medication regimen or new medication changes are some common factors that may worsen PD symptoms during hospitalization. More importantly, the inherent complexity of PD pathophysiology creates challenges in management. Therefore, understanding PD pathophysiology and recognizing care gaps enable optimization of inpatient care among this vulnerable population.

  1. Gerlach OHH, Broen MPG, van Domburg PHMF, Vermeij AJ, Weber WEJ. Deterioration of Parkinson’s disease during hospitalization: survey of 684 patients. BMC Neurol [Internet]. 2012;12:13. Available from: http://dx.doi.org/10.1186/1471-2377-12-13
  2. Guttman M, Slaughter PM, Theriault M-E, DeBoer DP, Naylor CD. Burden of parkinsonism: a population-based study. Mov Disord [Internet]. 2003;18(3):313–9. Available from: http://dx.doi.org/10.1002/mds.10333
  3. Zeldenrust F, Lidstone S, Wu S, Okun MS, Cubillos F, Beck J, et al. Variations in hospitalization rates across Parkinson’s Foundation Centers of Excellence. Parkinsonism Relat Disord [Internet]. 2020 [cited 2023 Apr 12];81:123–8. Available from: https://www.prd-journal.com/article/S1353-8020(20)30720-3/fulltext
  4. Gerlach OHH, Winogrodzka A, Weber WEJ. Clinical problems in the hospitalized Parkinson’s disease patient: systematic review: The hospitalized Parkinson’s disease patient. Mov Disord [Internet]. 2011;26(2):197–208. Available from: http://dx.doi.org/10.1002/mds.23449 
  5. Nóbrega AC, Rodrigues B, Melo A. Is silent aspiration a risk factor for respiratory infection in Parkinson’s disease patients? Parkinsonism Relat Disord [Internet]. 2008 [cited 2023 Apr 12];14(8):646–8. Available from: https://www.prd-journal.com/article/S1353-8020(08)00031-X/fulltext
  6. Temlett JA, Thompson PD. Reasons for admission to hospital for Parkinson’s disease. Intern Med J [Internet]. 2006;36(8):524–6. Available from: http://dx.doi.org/10.1111/j.1445-5994.2006.01123.x
  7. Klein C, Prokhorov T, Miniovitz A, Dobronevsky E, Rabey JM. Admission of Parkinsonian patients to a neurological ward in a community hospital. J Neural Transm (Vienna) [Internet]. 2009;116(11):1509–12. Available from: http://dx.doi.org/10.1007/s00702-009-0302-1
  8. Low V, Ben-Shlomo Y, Coward E, Fletcher S, Walker R, Clarke CE. Measuring the burden and mortality of hospitalisation in Parkinson’s disease: A cross-sectional analysis of the English hospital episodes statistics database 2009-2013. Parkinsonism Relat Disord [Internet]. 2015 [cited 2023 Apr 12];21(5):449–54. Available from: https://www.prd-journal.com/article/S1353-8020(15)00052-8/fulltext
  9. Hommel ALAJ, Krijthe JH, Darweesh S, Bloem BR. The association of comorbidity with Parkinson’s disease-related hospitalizations. Parkinsonism Relat Disord [Internet]. 2022 [cited 2023 Apr 12];104:123–8. Available from: https://www.prd-journal.com/article/S1353-8020(22)00332-7/fulltext
  10. Yu JRT, Walter BL. Addressing critical care gaps in inpatient Parkinson’s care - Minimizing the impact of comorbidities and developing new care delivery models. Parkinsonism Relat Disord [Internet]. 2022 [cited 2023 Apr 12];104:121–2. Available from: https://www.prd-journal.com/article/S1353-8020(22)00358-3/fulltext
  11. Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med [Internet]. 1967;276(7):374–9. Available from: http://dx.doi.org/10.1056/NEJM196702162760703
  12. Nutt JG. Pharmacokinetics and pharmacodynamics of levodopa: Pharmacokinetics and Pharmacodynamics of Levodopa. Mov Disord [Internet]. 2008;23 Suppl 3(S3):S580-4. Available from: http://dx.doi.org/10.1002/mds.22037
  13. Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, et al. Management of the hospitalized patient with Parkinson’s disease: current state of the field and need for guidelines. Parkinsonism Relat Disord [Internet]. 2011 [cited 2023 Apr 12];17(3):139–45. Available from: https://www.prd-journal.com/article/S1353-8020(10)00288-9/fulltext
  14. Nance MA, Boettcher L, Edinger G, Gardner J, Kitzmann R, Erickson LO, et al. Quality improvement in Parkinson’s disease: A successful program to enhance timely administration of levodopa in the hospital. J Parkinsons Dis [Internet]. 2020;10(4):1551–9. Available from: http://dx.doi.org/10.3233/JPD-202024
  15. Hou JG, Wu LJ, Moore S, Ward C, York M, Atassi F, et al. Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease. Parkinsonism Relat Disord [Internet]. 2012 [cited 2023 Apr 12];18(4):377–81. Available from: https://www.prd-journal.com/article/S1353-8020(11)00432-9/fulltext
  16. Richard G, Redmond A, Penugonda M, Bradley D. Parkinson’s disease medication prescribing and administration during unplanned hospital admissions. Mov Disord Clin Pract [Internet]. 2022;9(3):334–9. Available from: http://dx.doi.org/10.1002/mdc3.13408
  17. Yu J, Sonneborn C, Hogue O, Ghosh D, Brooks A, Liao J. Establishing a framework for quality of inpatient care for Parkinson’s disease: A study on inpatient medication administration. Parkinsonism and Related Disorders. Article in Press. 2023.
  18. Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, et al. Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy. Neurol Clin Pract [Internet]. 2017;7(1):86–93. Available from: http://dx.doi.org/10.1212/CPJ.0000000000000316
  19. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease: Systematic Review of LED Reporting in PD. Mov Disord [Internet]. 2010;25(15):2649–53. Available from: http://dx.doi.org/10.1002/mds.23429
  20. Schade S, Mollenhauer B, Trenkwalder C. Levodopa equivalent dose conversion factors: An updated proposal including opicapone and safinamide: LED for opicapone and safinamide. Mov Disord Clin Pract [Internet]. 2020;7(3):343–5. Available from: http://dx.doi.org/10.1002/mdc3.12921
  21. Pepper PV, Goldstein MK. Postoperative complications in Parkinson’s disease. J Am Geriatr Soc [Internet]. 1999;47(8):967–72. Available from: http://dx.doi.org/10.1111/j.1532-5415.1999.tb01292.x
  22. Ahlskog JE. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls. Mayo Clin Proc [Internet]. 2014 [cited 2023 Apr 12];89(7):997–1003. Available from: https://www.mayoclinicproceedings.org/article/S0025-6196(14)00249-3/fulltext
  23. Lertxundi U, Isla A, Solinís MÁ, Echaburu SD, Hernandez R, Peral-Aguirregoitia J, et al. Medication errors in Parkinson’s disease inpatients in the Basque Country. Parkinsonism Relat Disord [Internet]. 2017 [cited 2023 Apr 12];36:57–62. Available from: https://www.prd-journal.com/article/S1353-8020(16)30521-1/fulltext
  24. Grissinger M. Delayed administration and contraindicated drugs place hospitalized Parkinson’s disease patients at risk. P T. 2018;43(1):10–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29290668
  25. Lubomski M, Rushworth RL, Tisch S. Hospitalisation and comorbidities in Parkinson’s disease: a large Australian retrospective study. J Neurol Neurosurg Psychiatry [Internet]. 2015;86(3):324–30. Available from: http://dx.doi.org/10.1136/jnnp-2014-307822
  26. Lawson RA, McDonald C, Burn DJ. Defining delirium in idiopathic Parkinson’s disease: A systematic review. Parkinsonism Relat Disord [Internet]. 2019 [cited 2023 Apr 12];64:29–39. Available from: https://www.prd-journal.com/article/S1353-8020(18)30421-8/fulltext
  27. Golden WE, Lavender RC, Metzer WS. Acute postoperative confusion and hallucinations in Parkinson disease. Ann Intern Med [Internet]. 1989;111(3):218–22. Available from: http://dx.doi.org/10.7326/0003-4819-111-3-218 
  28. Oliver D, Daly F, Martin F, McMurdo M. Risk factors and risk assessment tools for falls in hospital in-patients: a systematic review. Age Ageing [Internet]. 2004 Mar 1;33(2):122–30. Available from: https://academic.oup.com/ageing/articlelookup/doi/10.1093/ageing/afh017
  29. Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RMA. Prevalence of orthostatic hypotension in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord [Internet]. 2011 [cited 2023 Apr 12];17(10):724–9. Available from: https://www.prd-journal.com/article/S1353-8020(11)00110-6/fulltext
  30. Matinolli M, Korpelainen JT, Korpelainen R, Sotaniemi KA, Myllylä VV. Orthostatic hypotension, balance and falls in Parkinson’s disease. Mov Disord [Internet]. 2009;24(5):745–51. Available from: http://dx.doi.org/10.1002/mds.22457
  31. Krauss MJ, Evanoff B, Hitcho E, Ngugi KE, Dunagan WC, Fischer I, et al. A case-control study of patient, medication, and care-related risk factors for inpatient falls. J Gen Intern Med [Internet]. 2005;20(2):116–22. Available from: http://dx.doi.org/10.1111/j.1525-1497.2005.40171.x
  32. Chang C-M, Chen M-J, Tsai C-Y, Ho L-H, Hsieh H-L, Chau Y-L, et al. Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study. Int J Geriatr Psychiatry [Internet]. 2011;26(6):602–7. Available from: http://dx.doi.org/10.1002/gps.2569
  33. Tanaka M, Suemaru K, Ikegawa Y, Tabuchi N, Araki H. Relationship between the risk of falling and drugs in an academic hospital. Yakugaku Zasshi [Internet]. 2008;128(9):1355–61. Available from: https://www.jstage.jst.go.jp/article/yakushi/128/9/128_9_1355/_article
  34. Martinez-Ramirez D, Giugni JC, Little CS, Chapman JP, Ahmed B, Monari E, et al. Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson’s disease patients. PLoS One [Internet]. 2015;10(4):e0124356. Available from: http://dx.doi.org/10.1371/journal.pone.0124356
  35. Fagerlund K, Anderson LC, Gurvich O. Perioperative medication withholding in patients with Parkinson’s disease: a retrospective electronic health records review. Am J Nurs [Internet]. 2013 [cited 2023 Apr 12];113(1):26–35; quiz 36. Available from: https://journals.lww.com/00000446-201301000-00024
  36. Ciucci MR, Grant LM, Rajamanickam ESP, Hilby BL, Blue KV, Jones CA, et al. Early identification and treatment of communication and swallowing deficits in Parkinson disease. Semin Speech Lang [Internet]. 2013;34(3):185–202. Available from: http://dx.doi.org/10.1055/s-0033-1358367
  37. Martinez-Ramirez D, Almeida L, Giugni JC, Ahmed B, Higuchi M-A, Little CS, et al. Rate of aspiration pneumonia in hospitalized Parkinson’s disease patients: a cross-sectional study. BMC Neurol [Internet]. 2015;15(1):104. Available from: http://dx.doi.org/10.1186/s12883-015-0362-9
  38. Mueller MC, Jüptner U, Wuellner U, Wirz S, Türler A, Hirner A, et al. Parkinson’s disease influences the perioperative risk profile in surgery. Langenbecks Arch Surg [Internet]. 2009;394(3):511–5. Available from: http://dx.doi.org/10.1007/s00423-008-0404-5
  39. Berganzo K, Díez-Arrola B, Tijero B, Somme J, Lezcano E, Llorens V, et al. Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related? J Neurol [Internet]. 2013;260(7):1752–6. Available from: http://dx.doi.org/10.1007/s00415-013-6859-5
  40. Palma J-A, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K, et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?: Diagnostic accuracy of OH criteria in PD. Mov Disord [Internet]. 2015;30(5):639–45. Available from: http://dx.doi.org/10.1002/mds.26079
  41. Lance S, Travers J, Bourke D. Reducing medication errors for hospital inpatients with Parkinsonism. Intern Med J [Internet]. 2021;51(3):385–9. Available from: http://dx.doi.org/10.1111/imj.14782
  42. Aslam S, Simpson E, Baugh M, Shill H. Interventions to minimize complications in hospitalized patients with Parkinson disease. Neurol Clin Pract [Internet]. 2020;10(1):23–8. Available from: http://dx.doi.org/10.1212/CPJ.0000000000000709
  43. Medications to be avoided or used with caution in Parkinson’s disease [Internet]. [cited 2023 Mar 21]. Available from: https://www.apdaparkinson.org/wpcontent/uploads/2018/05/APDA-Meds_to_Avoid.pdf
  44. Chou KL, Zamudio J, Schmidt P, Price CC, Parashos SA, Bloem BR, et al. Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism Relat Disord [Internet]. 2011 [cited 2023 Apr 12];17(6):440–5. Available from: https://www.prd-journal.com/article/S1353-8020(11)00061-7/fulltext
  45. Mehta S, Vankleunen JP, Booth RE, Lotke PA, Lonner JH. Total knee arthroplasty in patients with Parkinson’s disease: impact of early postoperative neurologic intervention. Am J Orthop (Belle Mead NJ). 2008;37(10):513–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19081879
  46. Skelly R, Brown L, Fakis A, Kimber L, Downes C, Lindop F, et al. Does a specialist unit improve outcomes for hospitalized patients with Parkinson’s disease? Parkinsonism Relat Disord [Internet]. 2014 [cited 2023 Apr 12];20(11):1242–7. Available from: https://www.prd-journal.com/article/S1353-8020(14)00337-X/fulltext
  47. Lertxundi U, Isla A, Solinis MA, Domingo-Echaburu S, Hernandez R, García-Moncó JC. A proposal to prevent omissions and delays of antiparkinsonian drug administration in hospitals. Neurohospitalist [Internet]. 2015;5(2):53–4. Available from: http://dx.doi.org/10.1177/1941874414566986
  48. Ebersbach G, Ip CW, Klebe S, Koschel J, Lorenzl S, Schrader C, et al. Management of delirium in Parkinson’s disease. J Neural Transm (Vienna) [Internet]. 2019;126(7):905–12. Available from: http://dx.doi.org/10.1007/s00702-019-01980-7
  49. Burbridge BE, Wallace JK, Rajput A, McCulloch L. Doppler ultrasonographic examination of the leg veins of patients with Parkinson disease. J Psychiatry Neurosci. 1999;24(4):338–40.  Available from: http://www.ncbi.nlm.nih.gov/pubmed/10516801
  50. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol [Internet]. 2010;67(1):58–63. Available from: http://dx.doi.org/10.1001/archneurol.2009.294
  51. Roark C, Whicher S, Abosch A. Reversible neurological symptoms caused by diathermy in a patient with deep brain stimulators: case report: Case report. Neurosurgery [Internet]. 2008 [cited 2023 Apr 12];62(1):E256; discussion E256. Available from: https://journals.lww.com/00006123-200801000-00028
  52. Nutt JG, Anderson VC, Peacock JH, Hammerstad JP, Burchiel KJ. DBS and diathermy interaction induces severe CNS damage. Neurology [Internet]. 2001;56(10):1384–6. Available from: http://dx.doi.org/10.1212/wnl.56.10.1384
  53. Weaver J, Kim SJ, Lee MH, Torres A. Cutaneous electrosurgery in a patient with a deep brain stimulator. Dermatol Surg [Internet]. 1999;25(5):415–7. Available from: http://journals.lww.com/00042728-199905000-00016

Articles related to the one you are viewing

There are currently no results to show, please try again later

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.